We don't typically re-publish here accusations that are unhelpful to the pharmaceutical industry.
But we figure once something has appeared on the front page of the business section of The New York Times, our blog has little power to add or detract.
So defense lawyers interested in accusations of ghostwriting of articles published in medical journals should click this link to "Medical Editors Push for Crackdown on Ghostwriting" from today's Times.
(Plaintiffs' lawyers: We're sorry to report that the previous link is broken. No reason to bother with it.)
Here's a link to PhRMA's principles on, among other things, the subject of giving authorship credit for articles. We are told that these principles "make ghostwriting a thing of the past."